Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-018328

Director bought 50,000 shares at an average $35.34 ($1,767,057)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lamond David Director 2021-03-04 Purchase +16,621 $34.28 $569,768 1,763,730 I: show line 1 in the form
Lamond David Director 2021-03-04 Purchase +13,310 $35.00 $465,850 1,777,040 I: show line 2 in the form
Lamond David Director 2021-03-04 Purchase +15,969 $36.34 $580,313 1,793,009 I: show line 3 in the form
Lamond David Director 2021-03-04 Purchase +4,100 $36.86 $151,126 1,797,109 I: show line 4 in the form
Open-market purchases · 50,000 sh · avg $35.34 · $1,767,057
Loading xslF345X03/doc4.xml…